Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience
2020 ◽
Keyword(s):
2005 ◽
Vol 74
(5)
◽
pp. 418-423
◽
2018 ◽
Vol 22
(6)
◽
pp. 1411-1419
◽
2016 ◽
Vol 6
(2)
◽
pp. 94-99
◽
Keyword(s):